Details for New Drug Application (NDA): 208169
✉ Email this page to a colleague
The generic ingredient in XURIDEN is uridine triacetate. There are thirty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the uridine triacetate profile page.
Summary for 208169
Tradename: | XURIDEN |
Applicant: | Btg Intl |
Ingredient: | uridine triacetate |
Patents: | 0 |
Pharmacology for NDA: 208169
Ingredient-type | Analogs/Derivatives Pyrimidines |
Suppliers and Packaging for NDA: 208169
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
XURIDEN | uridine triacetate | GRANULE;ORAL | 208169 | NDA | Wellstat Therapeutics Corporation | 69468-152 | 69468-152-02 | 2 g in 1 PACKET (69468-152-02) |
XURIDEN | uridine triacetate | GRANULE;ORAL | 208169 | NDA | Wellstat Therapeutics Corporation | 69468-152 | 69468-152-30 | 30 PACKET in 1 CARTON (69468-152-30) / 2 g in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 2GM/PACKET | ||||
Approval Date: | Sep 4, 2015 | TE: | RLD: | Yes |
Expired US Patents for NDA 208169
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Btg Intl | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription